Scan to download
BTC $75,672.87 +1.25%
ETH $2,352.82 +0.50%
BNB $630.83 +1.34%
XRP $1.45 +2.59%
SOL $88.49 +3.75%
TRX $0.3249 -0.21%
DOGE $0.0988 +2.85%
ADA $0.2576 +3.10%
BCH $449.62 +2.20%
LINK $9.52 +2.36%
HYPE $44.04 -2.55%
AAVE $115.08 +8.61%
SUI $0.9959 +1.83%
XLM $0.1684 +4.46%
ZEC $335.43 -2.13%
BTC $75,672.87 +1.25%
ETH $2,352.82 +0.50%
BNB $630.83 +1.34%
XRP $1.45 +2.59%
SOL $88.49 +3.75%
TRX $0.3249 -0.21%
DOGE $0.0988 +2.85%
ADA $0.2576 +3.10%
BCH $449.62 +2.20%
LINK $9.52 +2.36%
HYPE $44.04 -2.55%
AAVE $115.08 +8.61%
SUI $0.9959 +1.83%
XLM $0.1684 +4.46%
ZEC $335.43 -2.13%

The listed company Applied DNA Sciences plans to raise up to $58 million through a private placement to initiate its BNB financial strategy

2025-09-30 11:02:54
Collection

ChainCatcher news, according to businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has received a commitment for a private investment in public equity (PIPE) led by institutional investors, with a maximum amount of up to $58 million, to initiate a BNB-based digital asset financial strategy.

The company has secured a total of $27 million in funding commitments through PIPE, which includes cash, stablecoins, and OBNB trust units. In the future, by exercising warrants, the company also expects to receive up to $31 million in additional investment, bringing the total fundraising amount to a maximum of $58 million.

The PIPE transaction is expected to be completed around October 1, 2025. To support its BNB reserve strategy, the company has signed a five-year Strategic Digital Asset Services Agreement with Cypress LLC, which will provide full asset management services.

app_icon
ChainCatcher Building the Web3 world with innovations.